期刊文献+

地塞米松应用于肿瘤治疗的研究进展 被引量:16

Current applications of dexamethasone for cancer treatment
原文传递
导出
摘要 地塞米松是临床上广泛使用的糖皮质激素,其具有多种药理作用。近年来,地塞米松在癌症治疗中的应用日益增多,它可预防和缓解化疗药物带来的恶心、呕吐和疼痛等副作用;也可作为药物增敏剂来增强化疗药物的抗肿瘤效果,还在某些癌症治疗中用作抗肿瘤药物。地塞米松通过与糖皮质激素受体结合而介导多种信号通路,从而发挥抗炎、抗血管生成和激素调节等多种作用,对肿瘤的增殖、侵袭和转移等过程产生影响。 Dexamethasone is a synthetic glucocorticoid that is widely used in clinical due to its multiple pharmacological effects. Recently, dexamethasone is increasingly utilized in anti-cancer therapy. It is frequently used to prevent side effects of chemotherapy such as nausea, vomiting and pain, as well as to increase the anti-tumor activity of the cancer chemotherapeutic agents as a chemosensitizer and to inhibit tumor growth as an anti-cancer agent in some certain cancers. Dexamethasone produces the effects in anti-inflammation, anti-angiogenesis, control of estrogen activity and so on, by binding to glucocorticoid receptor to regulate gene expression of some important bio-signal molecules. Those signal pathways could interfere with the transcription of various factors which can regulate proliferation, invasion and metastasis of tumors.
机构地区 北京大学药学院
出处 《药学学报》 CAS CSCD 北大核心 2015年第10期1217-1224,共8页 Acta Pharmaceutica Sinica
基金 国家自然科学基金资助项目(81273583)
关键词 地塞米松 糖皮质激素 肿瘤 炎症 糖皮质激素受体 dexamethasone glucocorticoid cancer inflammation glucocorticoid receptor
  • 相关文献

参考文献3

二级参考文献13

  • 1Karin M, Yamamoto Y, Wang QM. The IKK NF-kappaB system: a treasure trove for drug development [J]. Nat Rev/Drug Discov, 2004,3(1):17-26.
  • 2Kucharczak J, Simmons MJ, Fan Y, et al. To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis [J]. Oncogene, 2003,22(56):8961-8982.
  • 3Zhou A, Scoggin S, Gaynor RB, et al. Identification of NF-kappaB-regulated genes induced by TNFalpha utilizing expression profiling and RNA interference [J]. Oncogene, 2003,22(13):2054-2064.
  • 4Matsuda A, Suzuki Y, Honda G, et al. Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways [J]. Oncogene, 2003,22(21):3307-3318.
  • 5Harper N, Farrow SN, Kaptein A, et al. Modulation of tumor necrosis factor apoptosis-inducing ligand-induced NF-kappaB activation by inhibition of apical caspases [J]. J Biol Chem, 2001,276(37):34743-34752.
  • 6Costas MA, Muller Igaz L, Holsboer F, et al. Transrepression of NF-kappaB is not required for glucocorticoid-mediated protection of TNF-alpha-induced apoptosis on fibroblasts [J]. Biochim Biophys Acta, 2000,1499(1-2):122-129.
  • 7Joussen AM, Poulaki V, Mitsiades N, et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression [J]. FASEB J, 2002,16(3):438-440.
  • 8Katsuyama K, Shichiri M, Kato H, et al. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells [J]. Endocrinology, 1999,140(5):2183-2190.
  • 9Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta [J]. Nature, 1998,396(6706):77-80.
  • 10Giardina C, Boulares H, Inan MS. NSAIDs and butyrate sensitize a human colorectal cancer cell line to TNF-alpha and Fas ligation: the role of reactive oxygen species [J]. Biochim Biophys Acta, 1999,1448(3):425-438.

共引文献48

同被引文献170

引证文献16

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部